Skip to main content
Premium Trial:

Request an Annual Quote

Lacks Honored by WHO

Henrietta Lacks, whose cancer cells were taken without her knowledge and fueled decades of biomedical research, has received a posthumous award from the World Health Organization for her contributions to science, according to the Associated Press.

"Henrietta Lacks was exploited. She is one of many women of color whose bodies have been misused by science," Tedros Adhanom Ghebreyesus, the WHO director-general, said in a ceremony honoring Lacks, according to the AP. "She placed her trust in the health system so she could receive treatment. But the system took something from her without her knowledge or consent."

As the New York Times notes, Tedros added that the inequality has continued, as HeLa cells have been used, for instance, to develop cervical cancer and COVID-19 vaccines that are not available to poorer nations. Groesbeck Parham, the chair of a WHO group on eliminating cervical cancer, said that the best way to honor Lacks' contribution to science would be to address inequities in science and medicine, the Times adds.

Last week, members of the Lacks family filed a lawsuit against Thermo Fisher Scientific for mass-producing and selling HeLa cells, and a lawyer for the Lacks family has said other companies may also be sued.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.